Schumacher Lab Publications

Fernández-Majada V, Welz PS, Ermolaeva MA, Schell M, Adam A, Dietlein F, Komander D, Büttner R, Thomas RK, Schumacher B, Pasparakis M.
The tumour suppressor CYLD regulates the p53 DNA damage response.
Nat Commun. 2016 Aug 26;7:12508. doi: 10.1038/ncomms12508.

Jokic M, Vlasic I, Rinneburger M, Klumper N, Spiro J, Vogel W, Offermann A, Kuempers C, Fritz C, Schmitt A, Riabinska A, Wittersheim M, Michels S, Ozretic L,
Florin A, Welcker D, Akyuz MD, Nowak M, Erkel M, Wolf J, Buttner R, Schumacher B, Thomale J, Persigehl T, Maintz D, Perner S, Reinhardt HC
Ercc1 Deficiency Promotes Tumorigenesis and Increases Cisplatin Sensitivity in a TP53 Context-specific Manner
Mol Cancer Res. 2016 Aug 11. pii: molcanres.0094.2016. [Epub ahead of print]

Willams AB, Schumacher B
p53 in the DNA-Damage-Repair Process.
Cold Spring Harb Perspect Med. 2016 Apr 5. pii: a026070. doi: 10.1101/cshperspect.a026070. [Epub ahead of print]

Barzilai A, Schumacher B, Shiloh, Y
Genome Instability: Linking Aging and Brain Degeneration.
Mech Ageing Dev. 2016 Mar 31. pii: S0047-6374(16)30039-2. doi: 10.1016/j.mad.2016.03.011. [Epub ahead of print]

Babu V, Schumacher B
A C. elegans homolog for the UV-hypersensitivity syndrome disease gene UVSSA.
DNA Repair (Amst). 2016 Mar 25;41:8-15. doi: 10.1016/j.dnarep.2016.03.008. [Epub ahead of print]

Braun F, Rinschen MM, Bartels V, Frommolt P, Habermann B, Hoeijmakers JH, Schumacher B, Dollé ME, Müller RU, Benzing T, Schermer B, Kurschat CE.
Altered lipid metabolism in the aging kidney identified by three layered omic analysis.
Aging (Albany NY). 2016 Feb 16.

Ribezzo F, Shiloh Y, Schumacher B.
Systemic DNA damage responses in aging and diseases.
Semin Cancer Biol. 2016 Jan 7. pii: S1044-579X(15)30005-5. doi: 10.1016/j.semcancer.2015.12.005

Nkuipou-Kenfack E, Bhat A, Klein J, Jankowski V, Mullen W, Vlahou A, Dakna M, Koeck T1 Schanstra JP, Zürbig P, Rudolph KL, Schumacher B, Pich A, Mischak H.
Identification of ageing-associated naturally occurring peptides in human urine.
Oncotarget 29 Sep 2015; doi: 10.18632/oncotarget.5896